A Novel Cocrystal of Daidzein with Piperazine to Optimize the Solubility, Permeability and Bioavailability of Daidzein
Molecules · 2024
DOI: 10.3390/molecules29081710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Zhipeng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Scienc…. Hauptthemen laut MEDLINE: Solubility, Biological Availability, Isoflavones, Piperazine. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, Chinese Pharmacopoeia Commission Drug Standard Promoting Fund.
Abstract (Originalsprache)
It is well known that daidzein has various significant medicinal values and health benefits, such as anti-oxidant, anti-inflammatory, anti-cancer, anti-diabetic, cholesterol lowering, neuroprotective, cardioprotective and so on. To our disappointment, poor solubility, low permeability and inferior bioavailability seriously limit its clinical application and market development. To optimize the solubility, permeability and bioavailability of daidzein, the cocrystal of daidzein and piperazine was prepared through a scientific and reasonable design, which was thoroughly characterized by single-crystal X-ray diffraction, powder X-ray diffraction, Fourier transform infrared spectroscopy, differential scanning calorimetry and thermogravimetric analysis. Combining single-crystal X-ray diffraction analysis with theoretical calculation, detailed structural information on the cocrystal was clarified and validated. In addition, a series of evaluations on the pharmacogenetic properties of the cocrystal were investigated. The results indicated that the cocrystal of daidzein and piperazine possessed the favorable stability, increased solubility, improved permeability and optimized bioavailability of daidzein. Compared with the parent drug, the formation of cocrystal, respectively, resulted in 3.9-, 3.1-, 4.9- and 60.8-fold enhancement in the solubility in four different media, 4.8-fold elevation in the permeability and 3.2-fold in the bioavailability of daidzein. Targeting the pharmaceutical defects of daidzein, the surprising elevation in the solubility, permeability and bioavailability of daidzein was realized by a clever cocrystal strategy, which not only devoted assistance to the market development and clinical application of daidzein but also paved a new path to address the drug-forming defects of insoluble drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- Beijing City Key Laboratory of Drug Target and Screening Research, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing…
ORCID-Profile: Shiying Yang, Dezhi Yang
Förderung
- the National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- Chinese Pharmacopoeia Commission Drug Standard Promoting Fund
- the Xinjiang Uygur Autonomous Region Innovation Environment Construction Special Fund and Technology Innovation Base Construction Key Laboratory Open Project
- National Natural Science Foundation of China
- Xinjiang Uygur Autonomous Region Innovation Environment Construction Special Fund and Technology Innovation Base Construction Key Laboratory Open Project
Zitieren
APA
Wang, Z., Li, S., Li, Q., Wang, W., Liu, M., Yang, S., Zhang, L., Yang, D., Du, G., & Lu, Y. (2024). A Novel Cocrystal of Daidzein with Piperazine to Optimize the Solubility, Permeability and Bioavailability of Daidzein. Molecules. https://doi.org/10.3390/molecules29081710
Vancouver
Wang Z, Li S, Li Q, Wang W, Liu M, Yang S, et al. A Novel Cocrystal of Daidzein with Piperazine to Optimize the Solubility, Permeability and Bioavailability of Daidzein. Molecules. 2024. doi:10.3390/molecules29081710
BibTeX
@article{Wang2024,
author = {Wang, Zhipeng and Li, Shuang and Li, Qi and Wang, Wenwen and Liu, Meiru and Yang, Shiying and Zhang, Li and Yang, Dezhi and Du, Guanhua and Lu, Yang},
title = {A Novel Cocrystal of Daidzein with Piperazine to Optimize the Solubility, Permeability and Bioavailability of Daidzein},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29081710}
}
EUVIMED